Salvia miltiorrhiza — known in Traditional Chinese Medicine as Dan Shen (丹参) — is the pre-eminent cardiovascular herb of the TCM pharmacopeia. Translated as "Cinnabar Root" for its vivid crimson color, Dan Shen has been used for over 2,000 years to invigorate blood, resolve stasis, calm the Heart spirit, and clear heat. Today it is among the most extensively researched TCM herbs, with hundreds of clinical studies validating its use in coronary artery disease, heart failure, stroke prevention, and fibrotic conditions.
TCM Classification & Energetics
- Category: Blood-Invigorating, Stasis-Resolving (活血化瘀)
- Taste & Temperature: Bitter, Slightly Cold
- Organ Systems: Heart, Pericardium, Liver
- Classical Actions: Invigorates blood and resolves stasis; clears heat and soothes irritability; nourishes blood and calms the Heart spirit (Shen)
In classical TCM, Dan Shen is said to equal the combined effect of four of the primary blood-nourishing herbs (Si Wu Tang) — reflecting its dual capacity to both move and nourish blood. It is a primary herb for xue yu (血瘀 — blood stasis) patterns, which in TCM underlie cardiovascular disease, chronic pain, dysmenorrhea, liver fibrosis, and fixed masses.
Key Bioactive Constituents
Dan Shen contains two primary classes of bioactive compounds:
Lipophilic Diterpene Quinones (Tanshinones)
- Tanshinone I, IIA, IIB: Primary cardioprotective, anti-inflammatory, and anti-tumor alkaloids
- Cryptotanshinone: Antidiabetic, anti-inflammatory, and androgen receptor modulating
- 15,16-Dihydrotanshinone I: Potent antimicrobial and anti-biofilm activity
Hydrophilic Phenolic Acids (Salvianolic Acids)
- Salvianolic acid A & B (Sal A, Sal B): Potent antioxidants; Sal B is among the most powerful natural antifibrotic compounds known
- Rosmarinic acid: Anti-inflammatory, antioxidant, neuroprotective
- Danshensu (3,4-DHPLA): Antiplatelet, vasodilatory, antioxidant — key for microcirculation
- Protocatechuic aldehyde: Cardioprotective; inhibits platelet aggregation and myocardial ischemia-reperfusion injury
Mechanisms of Action
1. Cardiovascular Protection
- Vasodilation: Tanshinone IIA and danshensu activate eNOS → nitric oxide (NO) production → smooth muscle relaxation and vasodilation
- Antiplatelet/antithrombotic: Danshensu and salvianolic acids inhibit TXA2 synthesis and platelet aggregation, reducing thrombotic risk without the bleeding risk of pharmaceutical anticoagulants
- Cardioprotection from ischemia-reperfusion: Tanshinone IIA reduces ROS burst during reperfusion; preserves mitochondrial membrane potential; inhibits cardiomyocyte apoptosis via Bcl-2/Bax pathway
- Anti-atherosclerotic: Inhibits oxidation of LDL, reduces foam cell formation, suppresses VCAM-1 and ICAM-1 adhesion molecules; reduces arterial plaque burden in animal models
- Antiarrhythmic: Modulates cardiac ion channels (L-type calcium, potassium); reduces triggered activity in ischemic myocardium
2. Antifibrotic Activity
Salvianolic acid B (Sal B) is among the most studied natural antifibrotic compounds:
- Inhibits TGF-β1/Smad signaling — the master pathway driving hepatic, renal, pulmonary, and cardiac fibrosis
- Suppresses hepatic stellate cell (HSC) activation and collagen I/III deposition
- Induces HSC apoptosis via mitochondrial pathway
- Reduces TIMP-1 and promotes MMP-mediated collagen degradation (fibrosis reversal)
- Clinical trials show meaningful reduction in liver fibrosis scores (Metavir, Ishak) in chronic HBV and NAFLD patients
3. Neuroprotection
- Tanshinone IIA crosses the blood-brain barrier and reduces neuroinflammation via NF-κB and MAPK inhibition
- Sal B protects neurons from amyloid-β toxicity — relevant to Alzheimer's prevention research
- Improves cerebral blood flow and reduces ischemic penumbra size in stroke models
- Rosmarinic acid inhibits MAO-A/B — potential antidepressant and neuroprotective effects
4. Anti-inflammatory & Antioxidant
- Tanshinone IIA inhibits NF-κB, STAT3, and AP-1 — broad anti-inflammatory transcription factor suppression
- Salvianolic acids are superoxide radical scavengers with ORAC values exceeding vitamin E
- Reduces TNF-α, IL-1β, IL-6, and MCP-1 in endothelial and macrophage models
5. Anti-tumor Activity
- Tanshinone IIA and cryptotanshinone induce apoptosis and cell cycle arrest in breast, lung, colon, prostate, and leukemia cell lines
- Inhibits tumor angiogenesis via VEGF/HIF-1α suppression
- Sensitizes cancer cells to doxorubicin and cisplatin — studied as a chemosensitizer
- Used adjunctively in integrative oncology; not a standalone treatment
Clinical Evidence & Applications
Coronary Artery Disease & Angina
- Compound Danshen Dripping Pills (CDDP) — a standardized Dan Shen formulation — is the most studied TCM cardiovascular product, with multiple Phase II/III trials including a US FDA IND trial
- Meta-analyses of 30+ RCTs show reduced angina frequency, improved exercise tolerance, and reduced nitroglycerin consumption compared to conventional care alone
- IV Dan Shen preparations used in Chinese hospitals for acute coronary syndromes as adjunct therapy
Heart Failure
- Improves LVEF, reduces BNP levels, and decreases hospitalization in chronic heart failure patients in multiple Chinese RCTs
- Cardioprotective during chemotherapy-induced cardiomyopathy (doxorubicin) in animal and early clinical data
Liver Fibrosis & NAFLD
- Sal B-based preparations reduce ALT/AST, improve liver elastography scores, and reduce fibrosis staging in HBV-related and NAFLD liver disease
- Phase II trials (China) show regression of fibrosis by 1 Metavir stage in 40–60% of patients after 48 weeks
Stroke & Cerebrovascular Disease
- Used widely in Chinese hospitals post-ischemic stroke for secondary prevention
- Reduces platelet hyperreactivity and improves microcirculation in cerebrovascular insufficiency
- Systematic reviews show improved neurological function scores vs. aspirin alone when combined
Dysmenorrhea & Gynecological Blood Stasis
- Classical TCM indication — Dan Shen resolves blood stasis in the Liver channel, reducing menstrual cramping and endometriosis-associated pain
- Often combined with Chuan Xiong and Yi Mu Cao for gynecological blood stasis patterns
Dosing & Forms
| Form | Standard Dose | Notes |
|---|---|---|
| Dried root (decoction) | 9–15g/day (up to 30g) | Classical decoction; higher doses for severe stasis |
| Standardized extract (tanshinone) | 500–1,000mg, 2x/day | Standardize to tanshinone IIA + salvianolic acid B content |
| Compound Danshen tablets/pills | Per product label | Most studied commercial form; pairs Dan Shen with notoginseng and borneol |
| IV preparation (hospital) | Clinical setting only | Used in Chinese hospitals for acute cardiovascular events |
Integrative Protocol: Cardiovascular Support
Foundation Stack:
- Dan Shen extract 500–1,000mg/day (standardized to Sal B + tanshinone IIA)
- CoQ10 200–400mg/day — mitochondrial support and synergistic cardioprotection
- Omega-3 EPA/DHA 2–4g/day — additive antiplatelet and anti-inflammatory effect
- Magnesium glycinate 400mg/day — vasodilation and antiarrhythmic support
For Liver Fibrosis:
- Dan Shen (Sal B-rich extract) + Milk Thistle (silymarin) 600–900mg/day
- NAC 1,200mg/day for glutathione support
- Berberine 500mg 2x/day if metabolic component (NAFLD)
For Blood Stasis / Microcirculation:
- Dan Shen + Chuan Xiong + Notoginseng (San Qi) — classical blood-moving trio
- Ginkgo biloba 120mg/day for cerebrovascular microcirculation
Safety, Contraindications & Drug Interactions
| Topic | Detail |
|---|---|
| Anticoagulants | High-priority interaction: Dan Shen significantly potentiates warfarin — increases INR unpredictably; avoid combination or monitor INR very closely |
| Antiplatelet drugs | Additive effect with aspirin, clopidogrel, NSAIDs — increased bleeding risk; use with caution and medical supervision |
| Digoxin | May alter digoxin pharmacokinetics — monitor levels if combined |
| CYP450 | Tanshinone IIA is a CYP3A4 inducer at higher doses — may reduce levels of drugs metabolized by CYP3A4 |
| Pregnancy | Contraindicated — blood-invigorating herbs are contraindicated in pregnancy due to uterotonic risk |
| Pre-surgery | Discontinue 2 weeks before surgery due to antiplatelet activity |
| Hypotension | Vasodilatory effect may potentiate antihypertensive medications — monitor BP |
Synergistic Combinations
- Dan Shen + San Qi (Notoginseng): The classic cardiovascular duo — Dan Shen moves and clears, San Qi stops bleeding and resolves stasis; together used for angina, stroke, and trauma
- Dan Shen + Chuan Xiong: Enhanced cerebrovascular and microcirculatory blood-moving action
- Dan Shen + Milk Thistle: Potent antifibrotic combination for liver disease — TGF-β and HSC suppression from both pathways
- Dan Shen + CoQ10: Synergistic mitochondrial and cardioprotective support
- Dan Shen + Suan Zao Ren (Ziziphus): Classical Shen-calming combination for Heart blood deficiency with insomnia, palpitations, and anxiety
Key Takeaways
- Dan Shen is TCM's most researched cardiovascular herb, with robust clinical evidence for coronary artery disease, heart failure, liver fibrosis, and stroke prevention
- Dual bioactive classes — tanshinones (lipophilic, cardioprotective, anti-tumor) and salvianolic acids (hydrophilic, antifibrotic, antioxidant) — provide complementary mechanisms
- Warfarin interaction is the most critical safety concern — must be flagged with any patient on anticoagulation
- Contraindicated in pregnancy; discontinue pre-surgery
- Pairs powerfully with Notoginseng, Milk Thistle, CoQ10, and Chuan Xiong for cardiovascular and hepatic protocols
0 comments